PodParley PodParley

#22: Mpox (formerly monkeypox) with Dr. Aaron Oom, Ph.D.

An episode of the Inflammatory Content podcast, hosted by Kellen Cavagnero, Ph.D., titled "#22: Mpox (formerly monkeypox) with Dr. Aaron Oom, Ph.D." was published on October 26, 2024 and runs 71 minutes.

October 26, 2024 ·71m · Inflammatory Content

0:00 / 0:00

In this episode, Kellen is joined by Dr. Aaron Oom, a Postdoctoral Scholar in the lab of Dr. Mark Mulligan at NYU Langone Health. Aaron is an expert in virology and immunology. He completed his Ph.D. in the lab of Dr. John Guatelli’s at UC San Diego. Aaron has made significant contributions to our understanding of viruses including HIV, Zika, and Dengue. Now, as a Postdoctoral Scholar in the Mulligan lab, he’s focused on Mpox (formerly known as monkeypox), which has recently re-emerged as a major global health threat. In this conversation, Kellen and Aaron discuss Aaron’s recent mpox publication, the challenges of transitioning to independence, the tough decisions around “killing” projects that aren’t working, and much more. Relevant Links:• Mulligan Lab Website: https://med.nyu.edu/research/mulligan-lab/• Aaron’s MedRxiv preprint: https://www.medrxiv.org/content/10.1101/2024.01.28.24301893v1• Mpox review: https://www.nature.com/articles/s41577-022-00775-4If you enjoy Inflammatory Content and want to help me keep the conversations going, consider supporting the podcast! You can write a review, share this episode with friends and colleagues, or make a donation to help keep the show ad-free and thriving. Your contributions, big or small, go directly toward covering production costs and allow me to bring you even more Inflammatory Content. You can donate directly here: https://venmo.com/Kellen-Cavagnero.I’d love to hear from you! Feel free to reach out with questions, feedback, or topic suggestions via email at [email protected], on X (formerly Twitter) @KellenCavagnero, or connect with me on LinkedIn.Stay curious and keep exploring at www.inflammatorycontent.com.

In this episode, Kellen is joined by Dr. Aaron Oom, a Postdoctoral Scholar in the lab of Dr. Mark Mulligan at NYU Langone Health. Aaron is an expert in virology and immunology. He completed his Ph.D. in the lab of Dr. John Guatelli’s at UC San Diego. Aaron has made significant contributions to our understanding of viruses including HIV, Zika, and Dengue. Now, as a Postdoctoral Scholar in the Mulligan lab, he’s focused on Mpox (formerly known as monkeypox), which has recently re-emerged as a major global health threat.

In this conversation, Kellen and Aaron discuss Aaron’s recent mpox publication, the challenges of transitioning to independence, the tough decisions around “killing” projects that aren’t working, and much more.

Relevant Links:

• Mulligan Lab Website: https://med.nyu.edu/research/mulligan-lab/

• Aaron’s MedRxiv preprint: https://www.medrxiv.org/content/10.1101/2024.01.28.24301893v1

• Mpox review: https://www.nature.com/articles/s41577-022-00775-4

If you enjoy Inflammatory Content and want to help me keep the conversations going, consider supporting the podcast! You can write a review, share this episode with friends and colleagues, or make a donation to help keep the show ad-free and thriving. Your contributions, big or small, go directly toward covering production costs and allow me to bring you even more Inflammatory Content. You can donate directly here: https://venmo.com/Kellen-Cavagnero.

I’d love to hear from you! Feel free to reach out with questions, feedback, or topic suggestions via email at [email protected], on X (formerly Twitter) @KellenCavagnero, or connect with me on LinkedIn.

Stay curious and keep exploring at www.inflammatorycontent.com.

3-Day Anti-Inflammatory Revitalize Challenge Anti-Inflammatory Living Discover the simple 3-step formula to reclaim your energy, reduce flare-ups & finally lose that stubborn weight Crohn’s & Colitis Foundation Perspectives ReachMD As research in inflammatory bowel diseases (IBD) advances, the landscape is rapidly evolving; requiring reinforcement of the most important and clinically relevant data. This educational series will provide the latest information on research, treatments, and management of IBD with a focus on the most pressing and relevant topics identified by the Crohn’s & Colitis Foundation's National Scientific Advisory Committee on Crohn’s Disease and Ulcerative Colitis. With 1.6 million Americans living with IBD, which includes Crohn’s disease and ulcerative colitis, and approximately 70,000 new cases diagnosed annually, the Crohn’s & Colitis Foundation is dedicated to developing and cultivating IBD healthcare providers through continued education and creation of valuable resources that directly impact the standard-of-care and everyday clinical practices in IBD. The Crohn’s & Colitis Foundation is the only national organization dedicated to driving efforts in IBD research, education and support f About IBD Amber J Tresca Crohn's disease and ulcerative colitis (collectively known as inflammatory bowel disease) are about more than diarrhea: they affect the whole person. About IBD focuses on health and lifestyle issues important to people living with Crohn's or colitis. IBD patients, doctors, therapists, and care partners give their tips and advice on topics including diet, nutrition, treatments, mental health, family dynamics, and sexuality as it relates to living with IBD. IBD Round Table Discussion ( Video ) – The Crohn's Colitis Effect The Crohns Colitis Effect The Crohn's Colitis Effect is a non-profit Inflammatory Bowel Disease advocacy group specializing in spreading awareness for IBD, Crohn's, and Colitis. Our monthly IBD Round Table Discussion brings some of the leading IBD Advocates together to talk about this invisible illness and what we can do to make life better. Regardless if you are a patient, caregiver, or just someone looking to educate themselves more about this gastrointestinal disease, there is something for everyone in these webcasts. Our mission is to make IBD a "household" name!
URL copied to clipboard!